Sienna Biopharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Sienna Biopharmaceuticals is scheduled to report earnings on October 9, 2020, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18
Income Statement	-
Total Revenue	$ 27.00K	$ 27.00K	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 27.00K	$ 27.00K	-	-	-
EBIT	$ -6.58M	$ -7.73M	$ -15.84M	$ -21.37M	$ -17.28M
EBITDA	$ -6.35M	$ -7.45M	$ -15.80M	$ -21.33M	$ -17.25M
Net Income Common Stockholders	$ -3.97M	$ -8.26M	$ -16.38M	$ -19.34M	$ -16.79M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 11.54M	$ 49.39M	$ 57.17M	$ 48.53M	$ 63.98M
Total Assets	$ 43.49M	$ 107.63M	$ 115.05M	$ 107.31M	$ 124.63M
Total Debt	$ 0.00	$ 30.02M	$ 29.82M	$ 30.13M	$ 29.98M
Net Debt	$ -11.54M	$ -19.37M	$ -27.34M	$ -18.40M	$ -33.99M
Total Liabilities	$ 20.39M	$ 80.64M	$ 81.77M	$ 80.72M	$ 79.70M
Stockholders Equity	$ 23.10M	$ 26.98M	$ 33.29M	$ 26.58M	$ 44.93M
Cash Flow	-
Free Cash Flow	$ 15.66M	$ -8.12M	$ -12.77M	$ -15.61M	$ -15.90M
Operating Cash Flow	$ 15.66M	$ -8.12M	$ -12.77M	$ -15.60M	$ -15.89M
Investing Cash Flow	$ -33.50M	$ -300.00K	$ -4.00K	$ -6.00K	$ -16.00K
Financing Cash Flow	$ -20.00M	$ 452.00K	$ 21.43M	$ 293.00K	$ 4.99M

Currency in USD

Sienna Biopharmaceuticals Earnings and Revenue History

Income Statement >

Sienna Biopharmaceuticals Debt to Assets

Balance Sheet >

Sienna Biopharmaceuticals Cash Flow

Cash Flow >

Sienna Biopharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing